1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)

Scope of the Report

The report titled “Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019)”, analyzes the potential opportunities and significant trends in the global in- vitro-fertilization market. The market size and forecast in value terms and number of IVF cycles for global IVF market has been provided for the period 2010 to 2019, considering 2014 as the base year. The report provides market share analysis of the global IVF market by regions, treatment costs, players and segments. The market is further segment by drug mechanism and different dosage forms.

The report provides detailed country analysis of the IVF markets of Australia, India and the United States. The market size and forecast both in terms of value and volume is covered in the country analysis segment. Also, the various factors driving growth have been analyzed specific to each country.

The report also profiles key market players such as Vitrolife, Monash IVF and OvaScience on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments.

Country Coverage

- United States
- India
- Australia

Company Coverage

- Monash Group
- OvaScience
- Vitrolife
?
Executive Summary

IVF stands for in-vitro-fertilization and refers to artificial fertilization for people that want to have a baby but are having difficulty getting pregnant.

Rising incidences of infertility as a consequence of increasing maternal age as more women are now starting families later in life is leading to a rise in demand for IVF treatment. Furthermore, lifestyle induced disorders such as obesity and smoking are contributing towards high infertility rates. These together are thus driving the in-vitro fertilization market, as women and their families prefer in-vitro fertilization procedure more compared to the other available procedures. The global in-vitro fertilization market is also witnessing lucrative growth with an increase in medical tourism activities in the developing economies such as India, China and Brazil. The major limiting factor of IVF market is the cost involved in the treatment. Another challenge is the low level of awareness in the developing economies.

The US emerged as the highest revenue contributing regional market for IVF in 2013. The growth of this market in the region is attributed to the presence of large population base suffering from infertility. Moreover, the availability of high disposable income with the people of this region is contributing to the growth of the IVF market. Asia Pacific is expected to grow at a highest CAGR over the forecasted period of 2015-2019 because of the presence of unmet medical needs coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies such as India, China and Japan. Australia has the highest market value and number of IVF cycles in the Asia-Pacific region. Furthermore, increasing medical tourism and availability of cost effective medical procedures in India are expected to positively reinforce In-Vitro fertilization market.

Table Of Contents

Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)
1. Executive Summary

2. In-Vitro-Fertilization (IVF): An Introduction
2.1 IVF Treatment Procedure
2.2 Causes of Infertility
2.4 Risk Related to IVF Treatment
2.4.1 Multiple Births
2.4.2 Premature Delivery and Low Birth Weight
2.4.3 Ovarian Hyperstimulation Syndrome
2.4.4 Miscarriage
2.4.5 Egg-Retrieval Procedure Complications
2.4.6 Ectopic Pregnancy
2.4.7 Birth Defects
2.4.8 Ovarian Cancer
2.4.9 Stress

3. In-Vitro-Fertilization (IVF): Global Market Analysis

3.1 Global IVF Market - Sizing and Growth: Actual and Forecast

3.2 Global IVF Market Share: An Analysis
3.2.1 Global IVF Market Share by IVF Cycles per Region
3.2.2 Global IVF Treatment Cost by Regions
3.2.3 Global Fertility Rates by Regions
3.2.4 Global IVF Penetration by Regions
3.2.5 Global IVF Market by Segments
3.2.6 Global IVF Market by Key Players
4. Country Analysis:In-Vitro-Fertilization (IVF) Market

4.1 Australia IVF Market: An Analysis

4.1.1 Australia IVF Market: Actual and Forecast
By Value
By Number of IVF Cycles

4.1.2 Australia IVF Market Drivers
Reproductive Age of Women
Increasing Penetration (% of women opting for IVF over natural conception)
Increasing Social Acceptance and Awareness
Fertility Rate
Affordability

4.2 India IVF Market: An Analysis

4.2.1 India IVF Market: Actual and Forecast
By Value
By Number of IVF Cycles

4.2.2 India IVF Market Drivers
Increasing Fertility Tourism
Declining Fertility Rate
Affordability

4.3 The US IVF Market: An Analysis

4.3.1 The US IVF Market: Actual and Forecast
By Value
By Number of IVF Procedures
By Number of Infants Births by Using IVF

4.3.2 The US IVF Market Breakdown
By Age Group
By Number of Embryos Transferred

4.3.3 The US IVF Market Drivers
Birth Rates
Declining Fertility Rates
Increasing Same Sex Married Couples
Obesity

4.3.4 US IVF Industry Landscape and MandA Activity

5. Market Dynamics: In-Vitro-Fertilization (IVF) Market

5.1 Growth Drivers
5.1.1 Decline in Fertility Rates
5.1.2 Delay in Motherhood
5.1.3 Rising Healthcare Expenditure
5.1.4 IVF Success Rates

5.2 Challenges
5.2.1 Physical and Emotional Impact
5.2.2 Legal Issues
5.2.3 Ethical Issues
5.2.4 Clinical Issues
5.2.5 Cost of the Treatment
5.2.6 Multiple Pregnancies

5.3 Market Trends
5.3.1 Medical Tourism
5.3.2 New Technology Trends
Robotic Surgery Used in Tubal Reversal
Transfer of Vitrified Embryos
Surrogate Alternatives
5.3.3 Rise in Same Sex Marriages

6. Competitive Landscape: In-Vitro-Fertilization (IVF) Market

7. Company Profiles: In-Vitro-Fertilization (IVF) Market

7.1 Monash
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Vitrolife
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 OvaScience
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

List of Figures and Tables

Figure 1: IVF Treatment Procedure
Figure 2: Causes of Infertility; 2013
Figure 3: Global Rate of Natural Conception by Age Group over a Year (%); 2014
Figure 4: Global IVF Market by Value; 2012-2014 (US$ Billion)
Figure 5: Global IVF Market by Value; 2015E-2019E (US$ Billion)
Figure 6: Global IVF Market Share by IVF Cycles per Regions; 2013
Figure 7: Global IVF Treatment Costs by Regions; 2014 (US$)
Figure 8: Global Fertility Rates by Regions; 2014
Figure 9: Global IVF Penetration (woman undertaking IVF as % of total births); 2013
Figure 10: Global IVF Market by Segments; 2013
Figure 11: Global IVF Market by Key Players; 2013
Figure 13: Australia Number of IVF Cycles per Women; 2009-2014
Figure 12: Australia Number of Fresh IVF Cycles per Women by Age Group; 2013
Figure 14: Australia IVF Market Size by Value; 2010-2014 (US$ Million)
Figure 15: Australia IVF Market Size by Value; 2015E-2019E (US$ Million)
Figure 16: Australia and New Zealand IVF Market Size by Number of IVF Cycles; 2008-2013
Figure 17: Australia and New Zealand IVF Market Size by Number of IVF Cycles; 2014E-2019E
Figure 18: Australia Female Population by Age Group; 2003-2013 (Millions)
Figure 19: IVF Penetration in Australia; 2002-2013
Figure 20: Australia Fertility Rates; 2005-2013 (births per women)
Figure 21: India IVF Market by Value; 2012-2014 (US$ Million)
Figure 22: India IVF Market by Value; 2015E-2019E (US$ Million)
Figure 23: India IVF Market by No. of IVF Cycles; 2014-2019E (in 000s)
Figure 24: India Fertility Rates; 2010-2014 (births per women)
Figure 25: The US Fertility Treatment Costs; 2014 (US$)
Figure 26: Cumulative Success Rate of IVF Procedure in the US; 2014
Figure 27: The US IVF Market by Value; 2010-2014 (US$ Billion)
Figure 28: The US IVF Market by Value; 2015E-2019E (US$ Billion)
Figure 29: The US IVF Market Size by Number of IVF Procedures; 2002-2014 (in 000s)
Figure 30: The US IVF Market Size by Number of IVF Procedures; 2014E-2019E (in 000s)
Figure 31: The US IVF Market Size by Number of Infants Births by Using IVF; 2002-2014 (in 000s)
Figure 32: The US IVF Market Size by Number of Infants Births by Using IVF; 2015E-2019E (in 000s)
Figure 33: Number of IVF Cycles in the US by Age Group; 2013
Figure 34: Average No. of Embryos Transferred in the US; 2013
Figure 35: Percentage of Transfers Resulting in Live Births in the US; 2013
Figure 36: The US Birth Rates by Age of Women; 1990-2013 (%)
Figure 37: The US Fertility Rates; 2005-2013
Figure 38: Infertility Rates by Age; 2014
Figure 39: Same Sex Married Couples in the US; 2008-2013
Figure 40: Growing Prevalence of Obesity among US Adults; 2012-2030
Figure 41: Global Fertility Rates; 1960-2015E
Figure 42: Global Birth Rate per 1000 Women; 1950-2013
Figure 43: Decline in Male Fertility with Age
Figure 44: Global Healthcare Expenditure, 2005-2013 (US$ Trillion)
Figure 45: GDP per Capita, 2003-2013 (US$)
Figure 46: Success Rates for IVF Treatments; 2013
Figure 47: The UK Live Birth Rates, 1992-2010
Figure 48: Monash Net Revenue; 2012-2014 (US$ Million)
Figure 49: Monash Net Revenue Breakdown; 2012-2014 (US$ Million)
Figure 50: Number of IVF Cycles vs. Revenue per Cycle; 2012-2016E
Figure 51: Monash Group Number of PGD/PGS Procedures; 2011-2014
Figure 52: Vitrolife Net Revenue; 2010-2014 (US$ Million)
Figure 53: OvaScience Net Revenue; 2015-2020E (US$ Million)
Table 1: India IVF Market Statistics; 2014 and 2020
Table 2: Obesity-Related Fertility Issues
Table 3: MandA Activity in IVF Industry in the US
Table 4: Comparative Analysis of IVF Industry Players; 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.